SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Vahanian Alec) srt2:(2005-2009)"

Search: WFRF:(Vahanian Alec) > (2005-2009)

  • Result 1-10 of 12
Sort/group result
   
EnumerationReferenceCoverFind
1.
  •  
2.
  • Graham, Ian, et al. (author)
  • European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
  • 2007
  • In: European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. - : Oxford University Press (OUP). - 1741-8267. ; 14 Suppl 2
  • Journal article (peer-reviewed)abstract
    • Other experts who contributed to parts of the guidelines: Edmond Walma, Tony Fitzgerald, Marie Therese Cooney, Alexandra Dudina European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG): Alec Vahanian (Chairperson), John Camm, Raffaele De Caterina, Veronica Dean, Kenneth Dickstein, Christian Funck-Brentano, Gerasimos Filippatos, Irene Hellemans, Steen Dalby Kristensen, Keith McGregor, Udo Sechtem, Sigmund Silber, Michal Tendera, Petr Widimsky, Jose Luis Zamorano Document reviewers: Irene Hellemans (CPG Review Co-ordinator), Attila Altiner, Enzo Bonora, Paul N. Durrington, Robert Fagard, Simona Giampaoli, Harry Hemingway, Jan Hakansson, Sverre Erik Kjeldsen, Mogens Lytken Larsen, Giuseppe Mancia, Athanasios J. Manolis, Kristina Orth-Gomer, Terje Pedersen, Mike Rayner, Lars Ryden, Mario Sammut, Neil Schneiderman, Anton F. Stalenhoef, Lale Tokgözoglu, Olov Wiklund, Antonis Zampelas
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  • Sinnaeve, Peter R., et al. (author)
  • Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations : Findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS
  • 2006
  • In: American Heart Journal. - : Elsevier BV. - 0002-8703 .- 1097-6744. ; 152:4, s. 684.e1-
  • Journal article (peer-reviewed)abstract
    • BACKGROUND: Elderly patients with acute myocardial infarction are at particularly high risk for death and bleeding complications. The efficacy and safety of antithrombotic strategies in these patients remain unclear. METHODS: To provide more insight into the risk and benefit of antithrombotic strategies in the elderly, we examined patients from the ASSENT-3 and ASSENT-3 PLUS trials with STEMI who were treated with tenecteplase (TNK) and unfractionated heparin (UFH) or enoxaparin, or half-dose TNK with abciximab and reduced-dose UFH. RESULTS: Older patients had a higher risk profile, and lower use of concomitant therapies and revascularization procedures. We found an interaction between age and treatment effect for the efficacy end point (P = .0007) and the efficacy plus safety end point (P < .0001). Younger patients (<65 years) had a lower risk of the composite efficacy plus safety end point with enoxaparin (relative risk [RR] 0.84, 95% CI 0.74-0.94) or abciximab (RR 0.79, 95% CI 0.69-0.90) compared with UFH. In patients >65 years of age, the benefit of enoxaparin appeared to be offset by an increased risk of bleeding complications. The risk of the efficacy plus safety end point tended to be higher in elderly patients receiving abciximab and half-dose TNK (RR 1.18, 95% CI 0.91-1.51 for 76-85 years of age and RR 1.48, 95% CI 0.88-2.49 for >85 years of age). CONCLUSIONS: Although TNK with either enoxaparin or abciximab appeared to be more effective than with standard UHF in younger patients, these combinations tended to be less effective and even may be unsafe in the elderly. Development of new combination strategies and dosing schemes of fibrinolytics and antithrombotics with improved efficacy and safety in the elderly remains a high priority.
  •  
7.
  •  
8.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-10 of 12
Type of publication
journal article (12)
Type of content
peer-reviewed (12)
Author/Editor
Zamorano, Jose Luis (12)
Vahanian, Alec (12)
Tendera, Michal (11)
Widimsky, Petr (11)
Dean, Veronica (11)
Filippatos, Gerasimo ... (11)
show more...
De Caterina, Raffael ... (11)
Dickstein, Kenneth (11)
Silber, Sigmund (11)
Sechtem, Udo (11)
Funck-Brentano, Chri ... (11)
McGregor, Keith (11)
Hellemans, Irene (11)
Camm, John (10)
Kristensen, Steen Da ... (8)
Priori, Silvia G (7)
Blomström-Lundqvist, ... (5)
De Backer, Guy (5)
Fagard, Robert (5)
Cifkova, Renata (5)
Ruilope, Luis (5)
Linde, Cecilia (4)
Drexler, Helmut (4)
Auricchio, Angelo (4)
Gasparini, Maurizio (4)
Vardas, Panos E (4)
Blanc, Jean-Jacques (4)
Oto, Ali (4)
Brignole, Michele (4)
Cleland, John (4)
Sutton, Richard (4)
Mancia, Giuseppe (4)
Le Heuzey, Jean-Yves (4)
Daubert, Jean-Claude (4)
Manolis, Athanasios ... (4)
Nilsson, Peter M (3)
Laurent, Stephane (3)
Lip, Gregory Y H (3)
Lindholm, Lars H (3)
Viigimaa, Margus (3)
Redon, Josep (3)
Narkiewicz, Krzyszto ... (3)
Grassi, Guido (3)
Kjeldsen, Sverre E. (3)
Schmieder, Roland E. (3)
Dalby Kristensen, St ... (3)
Dominiczak, Anna (3)
Zanchetti, Alberto (3)
Rynkiewicz, Andrzej (3)
Agabiti-Rosei, Enric ... (3)
show less...
University
Uppsala University (7)
University of Gothenburg (4)
Umeå University (3)
Lund University (1)
Karolinska Institutet (1)
Language
English (9)
Italian (1)
Polish (1)
Portuguese (1)
Research subject (UKÄ/SCB)
Medical and Health Sciences (2)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view